|
|
| Biotechnologies Et Génétique > Etude de marché sectorielle |
|
|
|
|
€ 976,00 |
Editeur
: |
Global Industry Analyst |
Langue
: |
Anglais |
Date de publication : |
Mai 2006 |
Taille du document : |
260 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (5) |
|
|
|
| 52 pages | Mars 2001 | Anglais
|
|
|
| Main
focus: |
biotechnology,bioinformatics,bio informatics,...,...
|
| Research
focus: |
market size and estimates,market segmentation, |
| Geographic
focus: |
canada,united kingdom,usa,france |
| |
|
|
|
|
| 271 pages | Juillet 2006 | Anglais
|
|
|
| Main
focus: |
biotechnology,biotech,biotech crops,bioinformatic,...,...
|
| Research
focus: |
competition analysis,market size and estimates, |
| Geographic
focus: |
france,united kingdom,hungary,czech republic,... |
| |
|
|
|
|
| 90 pages | Janvier 1998 | Anglais
|
|
|
| Main
focus: |
biotechnology,biotech,genetics,drug discovery,...
|
| Research
focus: |
competition analysis,market outlook, |
| Geographic
focus: |
usa,india,uruguay,chile,colombia,venezuela,... |
| |
|
|
|
|
| 44 pages | Juin 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceutical,pharmaceutical industry,...,...
|
| Research
focus: |
demand analysis,market size and estimates, |
| Geographic
focus: |
france,germany,united kingdom,japan,spain,... |
| |
|
|
|
|
| 44 pages | Janvier 2001 | Anglais
|
|
|
| Main
focus: |
biotechnology,biotech,biotechnology patents,...,...
|
| Research
focus: |
market size and estimates,market definition, |
| Geographic
focus: |
usa,switzerland,united kingdom,germany,france |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Lead Validation Platforms IRCD pages | Juillet 2001 |
The advent of brute force approaches to lead generation has highlighted a key bottleneck in drug development. The issue is not how many new compounds can one make per day, but rather how many c |
1 200,00 €
|
| |
| |
Nanotechnology: Emerging Trends
30 pages | Avril 2003 |
Recently, nanotechnology has become extremely popular and is used to describe many types of research where the characteristic dimensions are less than about 1,000 nanometers. Nanotechnology also pr |
550,00 €
|
| |
| |
Biotech Industry Potential: Emerging Markets & Trends 15 pages | Novembre 2002 |
The global biotech industry is comprised of 4,284 companies in 25 nations. The 622 public companies generated revenues of $35 billion, spent $16 billion in R&D and employed more than 188,000 people |
250,00 €
|
| |
| |
03-011: The Market for Real-Time PCR Reagents & Instrumentation 180 pages | Avril 2003 |
Based on a detailed 52-question survey of 406 scientists who currently perform qPCR, this report describes their research interests and specific applications |
640,00 €
|
| |
| |
Functional Proteomics and Emerging Bio-IT market pages | Novembre 2002 |
The proteomic technique is not only limited to the study of one or few cellular products but also allows for qualitative and a quantitative measurement of several hundreds of proteins produced during |
250,00 €
|
| |
| |
Antisense Therapy: Technical Aspects and Commercial Opportunities 334 pages | Mars 2000 |
Antisense therapy interferes with the expression of disease-causing proteins, thus offering a direct and selective intervention in the disease process. Besides the well known oligonucleotides ( |
955,00 €
|
| |
| |
Target and Lead Validation 160 pages | Décembre 2000 |
The advent of brute force approaches to lead generation has highlighted a key bottleneck in drug development. The issue is not how many new compounds can one make per day, but rather how many c |
1 400,00 €
|
| |
| |
DNA Computing-Tool for High-Performance Simulation 20 pages | Juillet 2002 |
The disciple of "DNA Computing" involves in cross-disciplinary research process between molecular and cellular biology involves the computational process in developing formal models of biological phen |
350,00 €
|
| |
| |
04-021: The U.S. Market for Synthetic Oligonucleotides: Establishing Differentiation for Success 183 pages | Avril 2004 |
This report provides a synopsis of both the DNA and RNA oligo market. It highlights the current and future research trends driving demand, as well as throughput levels, preferred formats, specialty |
1 200,00 €
|
| |
| |
03-018: Market Opportunities in Cytokine & Growth Factor Research 170 pages | Mai 2003 |
This report identifies preferred quantification and activity assays, new research trends and the most popular suppliers of antibodies, recombinant proteins and DNA microarrays |
800,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
|
|
The global outlook series on Biotechnology provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. Get a bird’s eye view of the Biotechnology industry, and gain a firm hold on market basics with 19 fact, and data rich tables presenting analytical segmentation by product application, global revenues of biotechnological companies, global R&D spends by leading companies, and global biotech/ pharmacogenomics/ Bioinformatics product/technology sales, among others. Take a sneak peek into major end-use industries, and take note of select trends in Genomics, Biochips, Biologics and Biopharmaceutical Intermediates, Biotechnology Instruments, and Biotechnology Reagents, among others. The research paper also provides a compilation of all recent mergers, acquisitions, and strategic corporate developments. A regional-level of discussion mirrors the prevalent scenario in key regional markets such as, the US, Canada, Mexico, Japan, France, Germany, Poland, UK, Sweden, Switzerland, New Zealand, India, Malaysia, and Brazil, among few others. Also included is an indexed, easy-to-refer, fact-finder directory listing the addresses, and contact details of 2,968 companies worldwide.
|
|
|
PPLSEN
|
|
|
|
|